EMEA recommends suspension of the marketing authorisation of Acomplia
- Details
- Category: EMA

European Medicines Agency recommends update of product information of Tysabri
- Details
- Category: EMA

FDA Approves Expanded Uses for Gardasil to Include Preventing Certain Vulvar and Vaginal Cancers
- Details
- Category: FDA

FDA Approves First Bone Marrow Stimulator to Treat Immune-Related Low Platelet Counts
- Details
- Category: FDA

European Medicines Agency recommends restricting the use of oral moxifloxacin-containing medicines
- Details
- Category: EMA

EMEA recommendation on use of angiotensin II receptor antagonists during pregnancy
- Details
- Category: EMA

FDA Issues Alert on Tussionex, a Long-Acting Prescription Cough Medicine Containing Hydrocodone
- Details
- Category: FDA

More Pharma News ...
- Wyeth Europa Ltd withdraws its marketing authorisation application for Pristiqs (desvenlafaxine)
- Actelion withdraws its application for an extension of indication for Zavesca
- FDA Licenses New Hemophilia Treatment
- Risk of peripheral neuropathy with Sebivo (telbivudine)
- EMEA recommends new warnings and contraindications for rosiglitazone
- EMEA recommends withdrawal of marketing authorisations for cough medicines containing clobutinol
- FDA Warns Procter & Gamble about Unlawful Marketing of Product for School Children